• Info
  • Insider Ownership

Insider Trading & Ownership of David Young

Location
Columbia, MD
Summary
The estimated net worth of David Young is at least $101K dollars as of 03 Oct 2025. David Young is the Pres. Research & Development, Director of Processa Pharmaceuticals, Inc. and owns shares of Processa Pharmaceuticals, Inc. (PCSA) stock worth about $101K.
Signature
/s/ David Young by John J. Wolfel, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when David Young files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of David Young

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PCSA Processa Pharmaceuticals, Inc. Pres. Research & Development, Director $101K 01 Oct 2025

Insider Transactions Reported by David Young:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.